====== Ocular Complications from Chemotherapeutic Agents ======

==== MEK inhibitors ====
  * Selumetinib, Binimetinib, Trametinib, Cobimetinib
    * Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation
    * Retinal pigment epithelial detachment, Central serous-like retinopathy 


====References====
  * {{::ocular_toxicity_of_mek_inhibitors_and_other_targeted_therapies.pdf |Ocular toxicities of MEK inhibitors and other targeted therapies. Stjepanovic et al. Annals of Oncology.Volume 27, Issue 6, June 2016, Pages 998-1005}}
  * {{::clinical_and_morphologic_characteristics_of_mek_inhibitor-associated_retinopathy.pdf |Clinical and Morphological Characteristics of MEK Inhibitor-Associated Retinopathy. Francis, Jasmine H. et al. Ophthalmology. 2017-12, Vol.124 (12), p.1788-1798 }}